Lansoprazole Capsule, Delayed Release
Product Images NDC 68788-7742

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 68788-7742). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lansoprazole Delayed Release Capsules Usp 30mg

Lansoprazole Delayed Release Capsules Usp 30mg
This is a medication label for Lansoprazole Delayed-Release Capsules. It includes details such as the quantity, prescription information, product and batch numbers, expiration date, and warnings. The warning cautions that the drug should only be used by the patient it was prescribed for and should be kept out of reach of children.*
FDA Label Image

F53ca2be-a290-4157-ad95-d24dfe3344f9-01 (F53ca2be A290 4157 Ad95 D24dfe3344f9 01)

FDA Label Image

F53ca2be-a290-4157-ad95-d24dfe3344f9-02 (F53ca2be A290 4157 Ad95 D24dfe3344f9 02)

F53ca2be-a290-4157-ad95-d24dfe3344f9-02 (F53ca2be A290 4157 Ad95 D24dfe3344f9 02)
The text provides a table showing the mean severity of day heartburn by study day for evaluable patients. The severity is indicated using a scale where 3 means severe, 2 means moderate, 1 means mild, and 0 means none. The study includes three groups: placebo, lansoprazole 15 mg GO, and lansoprazole 30 mg QD. The data is presented for 6 days from the start of treatment.*
FDA Label Image

F53ca2be-a290-4157-ad95-d24dfe3344f9-03 (F53ca2be A290 4157 Ad95 D24dfe3344f9 03)

F53ca2be-a290-4157-ad95-d24dfe3344f9-03 (F53ca2be A290 4157 Ad95 D24dfe3344f9 03)
Mean Severity of Night Heartburn By Study Day For Evaluable Patients is available. The table shows the mean severity of night heartburn on a scale of 0 to 3 for evaluable patients taking either placebo or Lansoprazole at different doses. Data is presented for up to 50 days from the start of treatment.*
FDA Label Image

F53ca2be-a290-4157-ad95-d24dfe3344f9-06 (F53ca2be A290 4157 Ad95 D24dfe3344f9 1)

FDA Label Image

F53ca2be-a290-4157-ad95-d24dfe3344f9-07 (F53ca2be A290 4157 Ad95 D24dfe3344f9 2)

FDA Label Image

Image (F53ca2be A290 4157 Ad95 D24dfe3344f9 7)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.